Bayer to Acquire Biotech AskBio for as Much as $4 Billion

(Bloomberg) -- Bayer AG agreed to acquire U.S. biotech company Asklepios BioPharmaceutical Inc. for as much as $4 billion, bolstering its pharma division with experimental gene therapies before pat...